- $20.91bn
- $20.02bn
- $1.70bn
Annual income statement for Natera, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 391 | 625 | 820 | 1,083 | 1,697 |
| Cost of Revenue | |||||
| Gross Profit | 187 | 307 | 364 | 493 | 1,023 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Unusual Expense / Income | |||||
| Total Operating Expenses | 613 | 1,094 | 1,361 | 1,529 | 1,919 |
| Operating Profit | -222 | -468 | -541 | -446 | -222 |
| Total Net Non Operating Interest Income / Expense | |||||
| Net Income Before Taxes | -230 | -471 | -547 | -435 | -190 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -230 | -472 | -548 | -435 | -190 |
| Net Income Before Extraordinary Items | |||||
| Net Income | -230 | -472 | -548 | -435 | -190 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -230 | -472 | -548 | -435 | -190 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -2.79 | -5.21 | -5.57 | -3.78 | -1.53 |